Human CD20 (Research Grade Rituximab Biosimilar) Antibody
R&D Systems, Inc. a Bio-Techne Brand
Key Product Details
Species Reactivity: | Human |
Immunogen: | Human CD20 |
Applications: | CyTOF-ready, Flow Cytometry |
Label: | Unconjugated |
Source: | Recombinant Monoclonal Human IgG1 Clone # Hu2 |
Specificity: |
Detects Human CD20 based on Rituximab therapeutic antibody. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Rituximab. This product is for research use only. |
Customers also Viewed
Customers also Purchased
Citations for Human CD20 (Research Grade Rituximab Biosimilar) Antibody
Please visit our Instrument Citation Database to search our collection of scientific articles that feature our instruments.
Customer Reviews for Human CD20 (Research Grade Rituximab Biosimilar) Antibody (1)
Customer Images
-
Application: FlowSample Tested: Peripheral blood mononuclear cells (PBMCs)Species: HumanVerified Customer | Posted 06/16/2020
There are no reviews that match your criteria.
FAQs for Human CD20 (Research Grade Rituximab Biosimilar) Antibody
-
What is a Biosimilar antibody?
A Biosimilar antibody is a non-therpeutic, recombinantly-expressed antibody which has the same sequence as the corresponding therapeutic antibody. It is for research use only. The nomenclature of the Biosimilar antibody includes the name of the therapeutic antibody. For example, Catalog # MAB9577 is called Human EGFR (Research Grade CetuxiMab Biosimilar) antibody.
-
Does this Biosimilar antibody have the same sequence as its corresponding therapeutic antibody?
This Biosimilar antibody has the same variable region sequence as the therapeutic antibody, but the constant region is not the same. It contains a proprietary human IgG constant region.